The Cheapest Way to Get a GLP-1 Without Insurance

Paying cash changes the question entirely. With insurance you are asking what your plan will approve; without it you are asking what the market charges, and the market charges an enormous range for the same molecule. Across the 556 sellers in this register, compounded semaglutide runs from about $79 a month to $299 at the ninetieth percentile, with a median near $190. Tirzepatide runs $99 to $399, median $264.

That spread — roughly four to one for the same drug — is the single most useful fact for a cash payer, and it is why a shopping page is worth more than a coupon. This is what the tiers actually are, what makes the cheap end cheap, and the four questions that decide whether the number you are quoted is the number you will pay.

What the market actually looks like

The distribution matters more than the minimum. If you are being quoted above the ninetieth percentile you are paying a premium for something — possibly a named pharmacy, a real clinician relationship or a flat-price guarantee, all of which are worth money, and possibly nothing. If you are being quoted at the very bottom, the questions below are the ones that tell you why.

What makes the cheap end cheap

A $79 monthly price is not usually a loss leader or a mistake. It is a set of trade-offs, and they are legible if you know where to look.

• A long prepayment. The lowest advertised figure is very often the twelve-month rate. The month-to-month price at the same seller can be double it. ⛔ “As low as” is doing specific work in that sentence.
• A starting dose. Where pricing rises with the dose, the advertised number is the bottom rung of the ladder, and the cost of a full titrated course is a different figure entirely.
• No named pharmacy. Most cheap sellers do not say who compounds the medication, which means you cannot check that pharmacy’s inspection or accreditation record before buying.
• Asynchronous care. A questionnaire reviewed by a clinician costs a fraction of a live video visit. That is legitimate and legal in most states, and it is less contact than some people need.
• Volume. Some sellers genuinely are cheaper because they are larger, and their compounding partner charges them less. This is the good version, and it is real.

The four questions that decide your real price

1. What is the billing cycle? A 28-day cycle bills 13 times a year, not 12 — so “$149 a month” is $1,937 a year rather than $1,788. The cycle usually appears in the terms, not on the price card.
2. Is that the month-to-month rate or a prepay rate? Ask for both. The gap is frequently larger than the gap between two different sellers.
3. Does the price change when the dose goes up? Flat pricing at every dose is genuinely valuable and worth confirming rather than assuming, because “all doses” sometimes means all doses up to a cap.
4. What is included? Medication, consult, shipping, labs. Two sellers at the same headline number can be selling materially different things, and shipping plus the consult is usually where the difference sits.

Check insurance first, even if you assume no

It is worth ten minutes before you commit to cash. Coverage for weight management is genuinely poor and frequently excluded outright — but an obstructive sleep apnea diagnosis, established cardiovascular disease or type 2 diabetes changes the question, because those are indications with completed outcomes trials behind them and insurers treat them differently from weight alone.

If a plan does cover it, the comparison is between your copay and these cash figures, and it is not always the copay that wins — a high-deductible plan can leave you paying the full brand price for months. Our guide to getting a GLP-1 covered walks the prior-authorization route, and the state Medicaid checker covers the public-program side.

Where the cheap end stops being a bargain

Below the prices in this register there is another market: peptides sold as “research chemicals” and labeled not for human consumption, at a fraction of any figure above. ⛔ There is no prescriber, no pharmacy, no accountable party and no way to establish what is in the vial. This register does not list those sellers, and nothing on this page should be read as covering them. Our piece on that market explains what it is and what it costs people.

Common questions

See the current numbers

The figures on this page were computed from the register in August 2026 and will drift. The cheapest semaglutide board and the cheapest tirzepatide board are generated from the current record, and every seller review carries its own price rows with the date each was read.